PlainPharmaWatch
CMS PY 2024 Company profile Open Payments data

CORCEPT THERAPEUTICS

CORCEPT THERAPEUTICS reported $4.2M in payments to physicians and teaching hospitals across 34,877 transactions in CMS Open Payments PY 2024.

Pharmaceutical payment transparency data for CORCEPT THERAPEUTICS. Ranked #287 of 1,797 companies by total payments. Source: CMS Open Payments, Program Year 2024.

Payment Overview

Total Payments

$4.2M

0.0% of all payments

Transactions

34,877

$119.88 avg

Recipients

34,550

$121.02 avg

Industry Rank

#287

of 1,797 companies

What the Data Shows for CORCEPT THERAPEUTICS

In Program Year 2024, CORCEPT THERAPEUTICS reported $4,181,168.42 in payments to 34,550 physicians and teaching hospitals across 34,877 individual transactions — an average of $119.88 per transaction and $121.02 per recipient. That total places CORCEPT THERAPEUTICS at rank #287 out of 1,797 companies in the CMS Open Payments database, representing 0.0% of all industry payments reported nationwide for the year. Payment volume at this scale is characteristic of manufacturers with broad prescriber engagement, active clinical research programs, or patented therapies generating ongoing royalty obligations.

The payment mix for CORCEPT THERAPEUTICS spans 8 distinct categories defined by CMS — including general payments (consulting, speaker fees, meals, travel), research payments tied to clinical trials, and ownership or investment interests. The largest single category is "Compensation for Services Other Than Consulting" at $1.9M, accounting for 45.0% of the company's reported total and 784 transactions. This distribution matters because different payment types carry different regulatory and ethical implications: research funding supports clinical development, while general payments like meals and speaker fees have been studied for their correlation with prescribing patterns in peer-reviewed journals such as JAMA Internal Medicine.

Recipient concentration is another useful lens. The top 5 recipients of payments from CORCEPT THERAPEUTICS received $0.00 combined — 0.0% of the company's total — with the remaining 100.0% distributed across the rest of the 34,550 recipients. A relatively distributed top-5 share suggests broader engagement across the prescriber community rather than concentration among a handful of high-value relationships. All figures above are drawn directly from the CMS Open Payments Public Use Files for PY2024 and are disclosed under the Physician Payments Sunshine Act; this page summarizes reported financial transfers and does not represent medical advice or judgment about individual prescribing decisions.

Payment Breakdown by Type

CORCEPT THERAPEUTICS made 8 types of payments. "Compensation for Services Other Than Consulting" accounts for 45.0%.

Compensation for Services Other Than Consulting $1.9M

45.0% · 784 transactions

Food and Beverage $873.1K

20.9% · 32,077 transactions

Travel and Lodging $451.7K

10.8% · 1,011 transactions

Honoraria $387.6K

9.3% · 106 transactions

Consulting Fee $229.4K

5.5% · 93 transactions

Space Rental or Facility Fees $44.0K

1.1% · 15 transactions

Grant $15.6K

0.4% · 3 transactions

Education $7.7K

0.2% · 461 transactions

Payment Type Amount Transactions
Compensation for Services Other Than Consulting $1.9M 784
Food and Beverage $873.1K 32,077
Travel and Lodging $451.7K 1,011
Honoraria $387.6K 106
Consulting Fee $229.4K 93
Space Rental or Facility Fees $44.0K 15
Grant $15.6K 3
Education $7.7K 461

Payment Size Analysis

Average transaction size: $119.88. Average per recipient: $121.02.

Total Amount

$4,181,168.42

Avg per Transaction

$119.88

Avg per Recipient

$121.02

Payment Transparency Context

The Physician Payments Sunshine Act (part of the Affordable Care Act) requires pharmaceutical and medical device manufacturers to report payments and transfers of value to physicians and teaching hospitals. These payments can include consulting fees, research grants, speaker fees, food and beverages, travel, royalties, and other forms of compensation.

Industry Total (2024)

$13.3B

across 1,797 companies

CORCEPT THERAPEUTICS Share

0.0%

#287 by total payments

Frequently Asked Questions

How much did CORCEPT THERAPEUTICS pay to physicians and hospitals in 2024?
CORCEPT THERAPEUTICS made $4,181,168.42 in payments to physicians and hospitals in Program Year 2024, across 34,877 individual transactions. This represents 0.0% of all industry payments reported to CMS Open Payments.
How many physicians received payments from CORCEPT THERAPEUTICS?
CORCEPT THERAPEUTICS made payments to 34,550 physicians and teaching hospitals in 2024. The average payment per recipient was $121.02.
What types of payments did CORCEPT THERAPEUTICS make?
CORCEPT THERAPEUTICS made 8 different types of payments. The largest category was "Compensation for Services Other Than Consulting" at $1.9M, representing 45.0% of all payments.
How does CORCEPT THERAPEUTICS rank among pharmaceutical companies?
CORCEPT THERAPEUTICS ranks #287 out of 1,797 companies by total payment amount in the CMS Open Payments database for 2024.
What is the average payment size from CORCEPT THERAPEUTICS?
The average transaction from CORCEPT THERAPEUTICS was $119.88 in 2024. The company made 34,877 total transactions to 34,550 recipients.
Are the top recipients concentrated for CORCEPT THERAPEUTICS?
The top 5 recipients received $0.00 from CORCEPT THERAPEUTICS, representing 0.0% of the company's total payments. Payments are relatively well-distributed across recipients.
Where does the payment data for CORCEPT THERAPEUTICS come from?
This data comes from the CMS Open Payments program (Sunshine Act), which requires pharmaceutical and medical device companies to report payments and transfers of value to physicians and teaching hospitals. The data covers Program Year 2024.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.3B across 1,797 companies.

Related

Data sourced from official U.S. government datasets. See our methodology for details. Retrieved and formatted by PlainPharmaWatch Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.